Welcome
The Complete Market Access Solution
for Small to Mid-sized Biopharmaceutical Companies
AxxessValue Solutions
Achieving Profitable Market Access
Achieving Profitable Market Access for Biopharmaceutical Companies is becoming an increasing challenge. It is estimated that in 2018 Gross-to-Net deductions were almost $170 billion. For many companies, Net Sales are about 55% to 60% of Gross Sales. And this trend is getting worse.
The critical issues then become:
- How to Balance Rebates and Copays to achieve optimal Formulary Access?
- How to manage and allocate Rebates among Priority Segments?
- How to allocate Rebates based on Payer's level of Control?
- Should Rebates be ignored in lieu of Copay Assistance Programs?
- Should Rebates be given to access better Formulary Positions?
- Should Prior Auths., Step Edits, be accepted when paying Rebates?
- How to deal with Complicated Price Protection schemes?
We achieve the Goal of Profitable Access by:
- Developing product and segment specific strategy based on a deep understanding of each customer
- Supporting contract decisions with a state-of-the- art customer database and analytics
- Executing the strategy with a proven customer engagement approach
AxxessValue Solutions provides the support to answer the above questions and achieve optimal Profitable Market Access for your Products.
Achieving Profitable Market Access